Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of Multimodal Deep Learning Models for Predicting Recurrence Patterns in Early-Stage Hepatocellular Carcinoma After Resection: A Natural Treatment Cohort Stratification Study

NCT07062380 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07062380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07062380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of Multimodal Deep Learning Models for Predicting Recurrence Patterns in Early-Stage Hepatocellular Carcinoma After Resection: A Natural Treatment Cohort Stratification Study
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2025
Completion date
June 10, 2028
Enrollment
353 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatecellular carcinoma, hepatectomy